Search | TVST | ARVO Journals

Showing 1 – 20 of 187

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Imaging in the Eye Conference Abstract July 2024

Method of Applying Deep Learning Model (DLM) Trained on OCT Images of Lower Axial Resolution to Images of Higher Axial Resolution without Model Retraining for Retinal Layer Segmentation

Yi-Zhong Wang; Mark E. Pennesi; Siyu Chen; David G. Birch

Invest. Ophthalmol. Vis. Sci.. 2024; 65(9):PB0013.

ARVO Annual Meeting Abstract June 2024

Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)

Xiangrong Kong; Yanzhao WANG; Folahan Adesola Ibukun; David G Birch; Elias Traboulsi; Janet S Sunness; Paul S Bernstein; Isabelle S Audo; Michel Michaelides; SriniVas R Sadda; Hendrik P Scholl; Eberhart Zrenner; Michael S Ip; Sheila K West; Artur V Cideciyan; Rupert Strauss

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2374.

ARVO Annual Meeting Abstract June 2024

SD-OCT Features and Macular Sensitivity in ABCA4 -related Stargardt disease (STGD1)

Yanzhao WANG; Folahan Adesola Ibukun; Elias Traboulsi; David G Birch; Janet S Sunness; Rupert Strauss; Isabelle S Audo; Michel Michaelides; SriniVas R Sadda; Hendrik P Scholl; Eberhart Zrenner; Michael S Ip; Artur V Cideciyan; Paul S Bernstein; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):975.

ARVO Annual Meeting Abstract June 2024

Longitudinal structure-function (S-F) relationship between short-wavelength autofluorescence (SW-FAF) and macular sensitivity (MS) in ABCA4 -associated Stargardt (STGD1) disease

Folahan Adesola Ibukun; Yanzhao Wang; Artur V Cideciyan; David G Birch; Janet S Sunness; Isabelle S Audo; Michel Michaelides; Elias Traboulsi; SriniVas R Sadda; Michael S Ip; Hendrik P Scholl; Rupert Strauss; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3350.

ARVO Annual Meeting Abstract June 2024

Impact of Training Dataset Size on Deep Learning Model’s Performance of Measuring Photoreceptor Outer Segment Metrics in Patients with Retinitis Pigmentosa (RP)

Yi-Zhong Wang; Katherine Juroch; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3743.

ARVO Annual Meeting Abstract June 2024

Baseline structural and functional findings from a PRPH2(p.Gly208Asp) natural history study

Rasha kako; Fritz Gerald Paguiligan Kalaw; Evan Walker; Naomi E. Wagner; Shaden Yassin; Ines Nagel; David G Birch; Borooah Shyamanga

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6668.

ARVO Annual Meeting Abstract June 2024

Subretinal gene therapy AGTC-501 for X-linked retinitis pigmentosa in the Phase 1/2 Horizon study: Post-hoc analysis of microperimetry results in the high dose groups

David G Birch; Andreas K Lauer; Paul Yang; Robert Sisk; Rajiv Anand; Darin Curtiss; Amy Christenson; Nadia K Waheed

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2133.

ARVO Annual Meeting Abstract June 2024

OCU400 Nuclear Hormone Receptor-Based Gene Modifier Therapy: Safety and Efficacy from Phase 1/2 Clinical Trial for Retinitis Pigmentosa Associated with NR2E3 and RHO Mutations

Byron L Lam; Arun K Upadhyay; Shankar Musunuri; Murthy Chavali; Sahar Matloob; Nalin Mehta; David G Birch; Paul Yang; Benjamin Bakall; Nieraj Jain; Jose S. Pulido; Borooah Shyamanga

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):406.

ARVO Annual Meeting Abstract June 2024

A Phase 1 First in Human Study of VP-001; a peptide conjugate of oligonucleotide designed to treat Retinitis Pigmentosa Type 11 patients

Fred Chen; David G Birch; Carla Jackson; Anna Mills; Laura Florez; Jessica Nichols; Paula Cunningham; Janya Grainok; Adam Martin; Subrata Das; Sue Fletcher; Clare Guerrero; Sri Mudumba

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1024.

ARVO Annual Meeting Abstract June 2024

Progressive vision loss related to sexual dimorphism in retinitis pigmentosa

Ashley Rowe; Tiffany Yee; Emily Nettesheim; David G Birch; Katherine J. Wert

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4894.

ARVO Annual Meeting Abstract June 2024

PRPH2 Gene Mutations and Associated Phenotypes in IRD patients with diverse genetic background.

Christopher Hallock; Riccardo Sangermano; Elfride De Baere; Siying Lin; Jennifer Thompson; Pascal Escher; Andrea L Vincent; Kaylie D Webb-Jones; Monika Grudzinska Pechhacker; Jacque L Duncan; Samer Khateb; Tamar Ben-Yosef; David G Birch; Andrew Webster; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5297.

Retina November 2023

Deep Learning–Facilitated Study of the Rate of Change in Photoreceptor Outer Segment Metrics in RPGR -Related X-Linked Retinitis Pigmentosa

PDF

Yi-Zhong Wang; Katherine Juroch; Yineng Chen; Gui-Shuang Ying; David G. Birch
TAGS: deep learning, photoreceptors, retinitis pigmentosa, volume, x-linked inheritance, eye, baseline value, follow-up, disease progression
Invest. Ophthalmol. Vis. Sci.. 2023; 64(14):31. https://doi.org/10.1167/iovs.64.14.31

Perspective June 2023

Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel

PDF

David G. Birch; Janet K. Cheetham; Stephen P. Daiger; Carel Hoyng; Christine Kay; Ian M. MacDonald; Mark E. Pennesi; Lori S. Sullivan
TAGS: gene therapy, mutation, natural history, phenotype, retinitis pigmentosa, x-linked inheritance, disease progression, blindness, retinal diseases, surrogate endpoints
Trans. Vis. Sci. Tech.. 2023; 12(6):5. https://doi.org/10.1167/tvst.12.6.5

ARVO Annual Meeting Abstract June 2023

Impact of High-Risk Features Associated with AMD Progression on Retinal Sensitivity

Houri Esmaeilkhanian; Muneeswar Gupta Nittala; Swetha B Velaga; David G Birch; Dwight Stambolian; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):296.

ARVO Annual Meeting Abstract June 2023

Deep Learning Facilitated Study of the Rate of Change in Photoreceptor Outer Segment (OS) Metrics in X-Linked Retinitis Pigmentosa (xlRP)

Yi-Zhong Wang; Katherine Juroch; Yineng Chen; Gui-Shuang Ying; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4640.

ARVO Annual Meeting Abstract June 2023

The Pro-EYS study: Baseline microperimetry, ellipsoid zone area, and central subfield retinal thickness

David G Birch

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4654.

ARVO Annual Meeting Abstract June 2023

Sensitivity of Confrontation Visual Fields in Detecting Field Loss Due to Retinitis Pigmentosa

Lauren Payne; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1469.

Retina May 2023

Monitoring Lesion Area Progression in Stargardt Disease: A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence

PDF

Vivienne C. Greenstein; David S. Castillejos; Stephen H. Tsang; Winston Lee; Janet R. Sparrow; Rando Allikmets; David G. Birch; Donald C. Hood
TAGS: face, fundus autofluorescence imaging, optical coherence tomography, stargardt's disease
Trans. Vis. Sci. Tech.. 2023; 12(5):2. https://doi.org/10.1167/tvst.12.5.2

Includes: Supplemental Content

Retina July 2022

Delineating the Clinical Phenotype of Patients With the c.629C>G, p.Pro210Arg Mutation in Peripherin-2

PDF

Shannon M. Conley; Cynthia K. McClard; Maggie L. Mwoyosvi; Niyaf Alkadhem; Bojana Radojevic; Martin Klein; David Birch; Ashley Ellis; Sonny W. Icks; Tejesh Guddanti; Lea D. Bennett
TAGS: mutation, phenotype, proteins, retina
Invest. Ophthalmol. Vis. Sci.. 2022; 63(8):19. https://doi.org/10.1167/iovs.63.8.19

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

18 Month Analysis of Macular Structure using Optical Coherence Tomography (OCT) from a Phase 1/2 Clinical Study of Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa

Paul Yang; Andreas Lauer; Mark E Pennesi; David G Birch; Rand Spencer; Robert Sisk; Alessandro Iannaccone; Matthew Feinsod; Mauro Goldbaum

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4399 – F0078.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Method of Applying Deep Learning Model (DLM) Trained on OCT Images of Lower Axial Resolution to Images of Higher Axial Resolution without Model Retraining for Retinal Layer Segmentation

Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)

SD-OCT Features and Macular Sensitivity in ABCA4 -related Stargardt disease (STGD1)

Longitudinal structure-function (S-F) relationship between short-wavelength autofluorescence (SW-FAF) and macular sensitivity (MS) in ABCA4 -associated Stargardt (STGD1) disease

Impact of Training Dataset Size on Deep Learning Model’s Performance of Measuring Photoreceptor Outer Segment Metrics in Patients with Retinitis Pigmentosa (RP)

Baseline structural and functional findings from a PRPH2(p.Gly208Asp) natural history study

Subretinal gene therapy AGTC-501 for X-linked retinitis pigmentosa in the Phase 1/2 Horizon study: Post-hoc analysis of microperimetry results in the high dose groups

OCU400 Nuclear Hormone Receptor-Based Gene Modifier Therapy: Safety and Efficacy from Phase 1/2 Clinical Trial for Retinitis Pigmentosa Associated with NR2E3 and RHO Mutations

A Phase 1 First in Human Study of VP-001; a peptide conjugate of oligonucleotide designed to treat Retinitis Pigmentosa Type 11 patients

Progressive vision loss related to sexual dimorphism in retinitis pigmentosa

PRPH2 Gene Mutations and Associated Phenotypes in IRD patients with diverse genetic background.

Deep Learning–Facilitated Study of the Rate of Change in Photoreceptor Outer Segment Metrics in RPGR -Related X-Linked Retinitis Pigmentosa

Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel

Impact of High-Risk Features Associated with AMD Progression on Retinal Sensitivity

Deep Learning Facilitated Study of the Rate of Change in Photoreceptor Outer Segment (OS) Metrics in X-Linked Retinitis Pigmentosa (xlRP)

The Pro-EYS study: Baseline microperimetry, ellipsoid zone area, and central subfield retinal thickness

Sensitivity of Confrontation Visual Fields in Detecting Field Loss Due to Retinitis Pigmentosa

Monitoring Lesion Area Progression in Stargardt Disease: A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence

Delineating the Clinical Phenotype of Patients With the c.629C>G, p.Pro210Arg Mutation in Peripherin-2

18 Month Analysis of Macular Structure using Optical Coherence Tomography (OCT) from a Phase 1/2 Clinical Study of Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa

To View More...

You must be signed into an individual account to use this feature.